Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-derived stromal vascular fraction for chronic lateral epicondylitis
IRCT20221104056393N3Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2023
- Modality
- Stem Cell Therapies → Cell Therapies, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of autologous adipose stromal vascular fraction and Normal Saline-Benha University in Lateral Epicondylitis (LET) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: QuickDASH score and Mayo Elbow Performance Index. Started Dec 2023; status: completed.
02
Drugs
autologous adipose stromal vascular fractionNormal Saline-Benha University
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on IRCT20221104056393N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221104056393N3.